Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects
| author | |
| created | [InstanceEdit:1358723] Orlic-Milacic, Marija, 2011-06-02 |
| dbId | 1358727 |
| displayName | Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects |
| journal | Cancer Res |
| modified | [InstanceEdit:8953471] D'Eustachio, Peter, 2016-12-22 |
| pages | 2601-9 |
| pubMedIdentifier | 15059917 |
| schemaClass | LiteratureReference |
| title | Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects |
| url | http://www.ncbi.nlm.nih.gov/pubmed/15059917 |
| volume | 64 |
| year | 2004 |
Referrals
© 2026 Reactome
